Tamura K, Honda T, Muto N, Bannai S
Jpn Heart J. 1975 Jul;16(4):361-76. doi: 10.1536/ihj.16.361.
The effects of dipyridamole (Persantin) on the coronary blood flow (the great cardiac vein flow and coronary sinus ostial flow), the femoral arterial pressure, the coronary vascular resistance and the heart rate were measured continuously in man. The newly devised method of the continuous local thermodilution method enabled us to perform the exact measurement of the above mentioned variables in man. The increase of the coronary blood flow was seen definitely in the non-ischemic group and, therefore, the decrease in the coronary vascular resistance occurred in 30 sec and continued for more than 20 min. In the myocardial ischemic group, some patients showed the similar response to the non-ischemic group. However, some patients showed no increase of the flow, even though the coronary vascular resistance decreased in all cases in this group. The heart rate increased slightly in all cases.
在人体中连续测量了双嘧达莫(潘生丁)对冠状动脉血流量(大心静脉血流和冠状窦口血流)、股动脉压、冠状血管阻力和心率的影响。新设计的连续局部热稀释法使我们能够在人体中精确测量上述变量。在非缺血组中确实观察到冠状动脉血流量增加,因此,冠状血管阻力在30秒内下降,并持续超过20分钟。在心肌缺血组中,一些患者表现出与非缺血组相似的反应。然而,在该组所有病例中,尽管冠状血管阻力下降,但一些患者的血流量并未增加。所有病例中心率均略有增加。